Ruplizumab

Names

[ CAS No. ]:
220651-94-5

[ Name ]:
Ruplizumab

[Synonym ]:
RUPLIZUMAB

Biological Activity

[Description]:

Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1].

[Related Catalog]:

Research Areas >> Inflammation/Immunology

[References]

[1]. Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.

Chemical & Physical Properties

No Any Chemical & Physical Properties